Nutrition and Alzheimer's disease: Pre-clinical concepts

European Journal of Neurology

Volumn 16, Issue SUPPL. 1, 2009, Pages 12-18

  Kamphuis, P J ^a   Wurtman, R J ^b  

^a DANONE RESEARCH   (Netherlands)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Alzheimer's disease; Amyloid; Cognitive decline; Dementia; Nutrition

Indexed keywords

AMYLOID BETA PROTEIN; ARACHIDONIC ACID; CHOLINE; CYANOCOBALAMIN; DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; PHOSPHATIDYLCHOLINE; PHOSPHOLIPID; POLYUNSATURATED FATTY ACID; POSTSYNAPTIC DENSITY PROTEIN 95; PYRIDOXINE; SYNAPSIN I; SYNTAXIN; SYNTAXIN 3; SYNUCLEIN; THIAMINE; UNCLASSIFIED DRUG; URIDINE; URIDINE PHOSPHATE;

ALZHEIMER DISEASE; BLOOD BRAIN BARRIER; BRAIN DEVELOPMENT; DENDRITIC SPINE; DIET SUPPLEMENTATION; LEARNING; LIPID COMPOSITION; MAZE TEST; MEMORY; NERVE CELL PLASTICITY; NEUROPROTECTION; NEUROTRANSMISSION; NONHUMAN; NUTRITION; PRIORITY JOURNAL; REVIEW; SYNAPSE; SYNAPTOGENESIS; TRANSMISSION ELECTRON MICROSCOPY;

ALZHEIMER DISEASE; ANIMALS; BRAIN; CHOLINE; FATTY ACIDS, UNSATURATED; HUMANS; MALNUTRITION; NERVE REGENERATION; NEURONAL PLASTICITY; PHOSPHOLIPIDS; SYNAPSES; URIDINE MONOPHOSPHATE;

EID: 69149088844     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2009.02737.x     Document Type: Review

References (62)

1. Blennow K, de MJ, Zetterberg H. Alzheimer's disease. Lancet 2006 368 : 387 403.
2. Cummings JL. Treatment of Alzheimer's disease: the role of symptomatic agents in an era of disease-modifying therapies. Rev Neurol Dis 2007 4 : 57 62.
3. Scarmeas N, Luchsinger JA, Mayeux R, Stern Y. Mediterranean diet and Alzheimer disease mortality. Neurology 2007 69 : 1084 1093.
4. Scarmeas N, Stern Y, Tang MX, Mayeux R, Luchsinger JA. Mediterranean diet and risk for Alzheimer's disease. Ann Neurol 2006 59 : 912 921.
5. Steele M, Stuchbury G, Munch G. The molecular basis of the prevention of Alzheimer's disease through healthy nutrition. Exp Gerontol 2007 42 : 28 36.
6. Gillette Guyonnet S, Abellan Van Kan G, Andrieu S, et al. IANA task force on nutrition and cognitive decline with aging. J Nutr Health Aging 2007 11 : 132 152.
7. Wurtman RJ, Ulus IH, Cansev M, Watkins CJ, Wang L, Marzloff G. Synaptic proteins and phospholipids are increased in gerbil brain by administering uridine plus docosahexaenoic acid orally. Brain Res 2006 1088 : 83 92.
8. Sakamoto T, Cansev M, Wurtman RJ. Oral supplementation with docosahexaenoic acid and uridine-5′-monophosphate increases dendritic spine density in adult gerbil hippocampus. Brain Res 2007 1182 : 50 59.
9. Nitsch RM, Blusztajn JK, Pittas AG, Slack BE, Growdon JH, Wurtman RJ. Evidence for a membrane defect in Alzheimer disease brain. Proc Natl Acad Sci U S A 1992 89 : 1671 1675.
10. Scheff SW, Price DA, Schmitt FA, Mufson EJ. Hippocampal synaptic loss in early Alzheimer's disease and mild cognitive impairment. Neurobiol Aging 2006 27 : 1372 1384.
11. Spittaels K, Van den Haute C, Van Dorpe J, et al. Prominent axonopathy in the brain and spinal cord of transgenic mice overexpressing four-repeat human tau protein. Am J Pathol 1999 155 : 2153 2165.
12. Bourre JM, Dumont O, Piciotti M, et al. Essentiality of omega 3 fatty acids for brain structure and function. World Rev Nutr Diet 1991 66 : 103 117.
13. Lauritzen L, Hansen HS, Jorgensen MH, Michaelsen KF. The essentiality of long chain n-3 fatty acids in relation to development and function of the brain and retina. Prog Lipid Res 2001 40 : 1 94.
14. Bazan NG, Scott BL. Dietary omega-3 fatty acids and accumulation of docosahexaenoic acid in rod photoreceptor cells of the retina and at synapses. Ups J Med Sci Suppl 1990 48 : 97 107.
15. Ansari KA, Shoeman DW. Arachidonic and docosahexanoic acid content of bovine brain myelin: implications for the pathogenesis of multiple sclerosis. Neurochem Res 1990 15 : 7 11.
16. Yehuda S, Rabinovitz S, Carasso RL, Mostofsky DI. The role of polyunsaturated fatty acids in restoring the aging neuronal membrane. Neurobiol Aging 2002 23 : 843 853.
17. McCann JC, Ames BN. Is docosahexaenoic acid, an n-3 long-chain polyunsaturated fatty acid, required for development of normal brain function? An overview of evidence from cognitive and behavioral tests in humans and animals Am J Clin Nutr 2005 82 : 281 295.
18. Litman BJ, Mitchell DC. A role for phospholipid polyunsaturation in modulating membrane protein function. Lipids 1996 31 : S193 S197.
19. Barcelo-Coblijn G, Kitajka K, Puskas LG, et al. Gene expression and molecular composition of phospholipids in rat brain in relation to dietary n-6 to n-3 fatty acid ratio. Biochim Biophys Acta 2003 1632 : 72 79.
20. Green P, Glozman S, Kamensky B, Yavin E. Developmental changes in rat brain membrane lipids and fatty acids. The preferential prenatal accumulation of docosahexaenoic acid. J Lipid Res 1999 40 : 960 966.
21. Angulo-Guerrero O, Oliart RR. Effects of dietary polyunsaturated fatty acids on rat brain plasma membrane fatty acid composition. Arch Latinoam Nutr 1998 48 : 287 292.
22. Horrocks LA, Yeo YK. Health benefits of docosahexaenoic acid (DHA). Pharmacol Res 1999 40 : 211 225.
23. Conquer JA, Tierney MC, Zecevic J, Bettger WJ, Fisher RH. Fatty acid analysis of blood plasma of patients with Alzheimer's disease, other types of dementia, and cognitive impairment. Lipids 2000 35 : 1305 1312.
24. Tully AM, Roche HM, Doyle R, et al. Low serum cholesteryl ester-docosahexaenoic acid levels in Alzheimer's disease: a case-control study. Br J Nutr 2003 89 : 483 489.
25. Soderberg M, Edlund C, Kristensson K, Dallner G. Fatty acid composition of brain phospholipids in aging and in Alzheimer's disease. Lipids 1991 26 : 421 425.
26. Grant WB, Campbell A, Itzhaki RF, Savory J. The significance of environmental factors in the etiology of Alzheimer's disease. J Alzheimers Dis 2002 4 : 179 189.
27. Morris MC, Evans DA, Bienias JL, et al. Consumption of fish and n-3 fatty acids and risk of incident Alzheimer disease. Arch Neurol 2003 60 : 940 946.
28. Kalmijn S, van Boxtel MP, Ocke M, Verschuren WM, Kromhout D, Launer LJ. Dietary intake of fatty acids and fish in relation to cognitive performance at middle age. Neurology 2004 62 : 275 280.
29. Sastry PS. Lipids of nervous tissue: composition and metabolism. Prog Lipid Res 1985 24 : 69 176.
30. Kennedy EP, Weiss SB. The function of cytidine coenzymes in the biosynthesis of phospholipides. J Biol Chem 1956 222 : 193 214.
31. Cornford EM, Braun LD, Oldendorf WH. Carrier mediated blood-brain barrier transport of choline and certain choline analogs. J Neurochem 1978 30 : 299 308.
32. Hashimoto M, Hossain S, Shimada T, et al. Docosahexaenoic acid provides protection from impairment of learning ability in Alzheimer's disease model rats. J Neurochem 2002 81 : 1084 1091.
33. Spector AA. Plasma free fatty acid and lipoproteins as sources of polyunsaturated fatty acid for the brain. J Mol Neurosci 2001 16 : 159 165.
34. Li JY, Boado RJ, Pardridge WM. Cloned blood-brain barrier adenosine transporter is identical to the rat concentrative Na+ nucleoside cotransporter CNT2. J Cereb Blood Flow Metab 2001 21 : 929 936.
35. Araki W, Wurtman RJ. How is membrane phospholipid biosynthesis controlled in neural tissues? J Neurosci Res 1998 51 : 667 674.
36. Spanner S, Ansell GB. Choline kinase and ethanolamine kinase activity in the cytosol of nerve endings from rat forebrain. Biochem J 1979 178 : 753 760.
37. Millington WR, Wurtman RJ. Choline administration elevates brain phosphorylcholine concentrations. J Neurochem 1982 38 : 1748 1752.
38. Suzuki NN, Koizumi K, Fukushima M, Matsuda A, Inagaki F. Structural basis for the specificity, catalysis, and regulation of human uridine-cytidine kinase. Structure 2004 12 : 751 764.
39. Genchev DD, Mandel P. CTP synthetase activity in neonatal and adult rat brain. J Neurochem 1974 22 : 1027 1030.
40. Ross BM, Moszczynska A, Blusztajn JK, Sherwin A, Lozano A, Kish SJ. Phospholipid biosynthetic enzymes in human brain. Lipids 1997 32 : 351 358.
41. Cansev M, Wurtman RJ. Chronic administration of docosahexaenoic acid or eicosapentaenoic acid, but not arachidonic acid, alone or in combination with uridine, increases brain phosphatide and synaptic protein levels in gerbils. Neuroscience 2007 148 : 421 431.
42. Cansev M, Watkins CJ, van der Beek EM, Wurtman RJ Oral uridine-5′-monophosphate (UMP) increases brain CDP-choline levels in gerbils. Brain Res 2005 1058 : 101 108. Epub 2005 Aug 2029.
43. Pooler AM, Guez DH, Benedictus R, Wurtman RJ. Uridine enhances neurite outgrowth in nerve growth factor-differentiated PC12 [corrected]. Neuroscience 2005 134 : 207 214.
44. Wang L, Pooler AM, Albrecht MA, Wurtman RJ. Dietary uridine-5′- monophosphate supplementation increases potassium-evoked dopamine release and promotes neurite outgrowth in aged rats. J Mol Neurosci 2005 27 : 137 145.
45. Cansev M, Wurtman RJ, Sakamoto T, Ulus IH. Oral administration of circulating precursors for membrane phosphatides can promote the synthesis of new brain synapses. Alzheimer's Dement 2008 4 : S153 S168.
46. De Wilde MC, Groenendijk M, Kamphuis PJ, Broersen LM. Effects of dietary lipids and other nutrients on membrane and synapse formation. Proc. 8th Dutch ENP Meeting, p. 71.
47. Ikemoto A, Kobayashi T, Watanabe S, Okuyama H. Membrane fatty acid modifications of PC12 cells by arachidonate or docosahexaenoate affect neurite outgrowth but not norepinephrine release. Neurochem Res 1997 22 : 671 678.
48. Fujii A, Matsumoto H, Yamamoto H. Effect of vitamin B complex on neurotransmission and neurite outgrowth. Gen Pharmacol 1996 27 : 995 1000.
49. Ulus IH, Wurtman RJ, Mauron C, Blusztajn JK. Choline increases acetylcholine release and protects against the stimulation-induced decrease in phosphatide levels within membranes of rat corpus striatum. Brain Res 1989 484 : 217 227.
50. Wang L, Albrecht MA, Wurtman RJ. Dietary supplementation with uridine-5′-monophosphate (UMP), a membrane phosphatide precursor, increases acetylcholine level and release in striatum of aged rat. Brain Res 2007 1133 : 42 48.
51. Teather LA, Wurtman RJ. Chronic administration of UMP ameliorates the impairment of hippocampal-dependent memory in impoverished rats. J Nutr 2006 136 : 2834 2837.
52. De Bruin NM, Kiliaan AJ, De Wilde MC, Broersen LM. Combined uridine and choline administration improves cognitive deficits in spontaneously hypertensive rats. Neurobiol Learn Mem 2003 80 : 63 79.
53. Calon F, Lim GP, Yang F, et al. Docosahexaenoic acid protects from dendritic pathology in an Alzheimer's disease mouse model. Neuron 2004 43 : 633 645.
54. Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 2002 297 : 353 356.
55. Wolozin B. A fluid connection: cholesterol and Abeta. Proc Natl Acad Sci U S A 2001 98 : 5371 5373.
56. de Wilde MC, Leenders I, Broersen LM, Kuipers AAM, van der Beek EM, Kiliaan AJ The Omega-3 Fatty Acid Docosahexaenoic Acid (DHA) Inhibits the Formation of Beta Amyloid in CHO7PA2 Cells. Program Number 730.11, New Orleans, LA : Society for Neuroscience Meeting, 2003.
57. Lim GP, Calon F, Morihara T, et al. A diet enriched with the omega-3 fatty acid docosahexaenoic acid reduces amyloid burden in an aged Alzheimer mouse model. J Neurosci 2005 25 : 3032 3040.
58. Oksman M, Iivonen H, Hogyes E, et al. Impact of different saturated fatty acid, polyunsaturated fatty acid and cholesterol containing diets on beta-amyloid accumulation in APP/PS1 transgenic mice. Neurobiol Dis 2006 23 : 563 572.
59. Hashimoto M, Tanabe Y, Fujii Y, Kikuta T, Shibata H, Shido O. Chronic administration of docosahexaenoic acid ameliorates the impairment of spatial cognition learning ability in amyloid beta-infused rats. J Nutr 2005 135 : 549 555.
60. Broersen L, De Wilde M, Leenders I, et al. Reduced beta-amyloid plaque burden and neurodegeneration in APP/PS1 transgenic mice following multi-nutrient dietary intervention. Soc Neurosci Abstr. 2007 : 157.116/U127.
61. van der Beek EM, Kuipers A, Broersen L, Leenders I, Kamphuis P, De MC Dietary Intervention Improves Cholinergic Function. Program No. 467.13, Atlanta, GA : Society for Neuroscience Meeting, 2006.
62. Wurtman RJ, Cansev M, Sakamoto T, Ulus IH. Oral administration of circulating precursors for membrane phosphatides can promote the synthesis of new brain synapses. Alzheimer's Dement 2008 4 : S153 S168.